相似文献
1
Standardization & validation of Truenat™ point-of-care test for rapid diagnosis of Nipah.
Indian J Med Res. 2021 Apr;154(4):645-649. doi: 10.4103/ijmr.IJMR_4717_20.
2
Performance evaluation of Truenat™ Beta CoV & Truenat™ SARS-CoV-2 point-of-care assays for coronavirus disease 2019.
Indian J Med Res. 2021;153(1 & 2):144-150. doi: 10.4103/ijmr.IJMR_2363_20.
3
Multicentric validation of indigenous molecular test Truenat™ MTB for detection of in sputum samples from presumptive pulmonary tuberculosis patients in comparison with reference standards.
Indian J Med Res. 2020 Oct;152(4):378-385. doi: 10.4103/ijmr.IJMR_2539_19.
4
Nipah@20: Lessons Learned from Another Virus with Pandemic Potential.
mSphere. 2020 Jul 8;5(4):e00602-20. doi: 10.1128/mSphere.00602-20.
5
Survival and persistence of Nipah virus in blood and tissue culture media.
Emerg Microbes Infect. 2019;8(1):1760-1762. doi: 10.1080/22221751.2019.1698272.
6
Specific detection of Nipah virus using real-time RT-PCR (TaqMan).
J Virol Methods. 2004 Sep 15;120(2):229-37. doi: 10.1016/j.jviromet.2004.05.018.
7
Nipah virus circulation at human-bat interfaces, Cambodia.
Bull World Health Organ. 2020 Aug 1;98(8):539-547. doi: 10.2471/BLT.20.254227. Epub 2020 Jun 19.
8
Nipah pseudovirus system enables evaluation of vaccines in vitro and in vivo using non-BSL-4 facilities.
Emerg Microbes Infect. 2019;8(1):272-281. doi: 10.1080/22221751.2019.1571871.
9
A solid-phase blocking ELISA for detection of antibodies to Nipah virus.
J Virol Methods. 2004 Nov;121(2):259-61. doi: 10.1016/j.jviromet.2004.06.015.
10
Infections among Contacts of Patients with Nipah Virus, India.
Emerg Infect Dis. 2020 Aug;26(8):1963. doi: 10.3201/eid2608.190722.
引用本文的文献
1
Nipah virus: pathogenesis, genome, diagnosis, and treatment.
Appl Microbiol Biotechnol. 2025 Jul 1;109(1):158. doi: 10.1007/s00253-025-13474-6.
2
Bangladesh Sees Spike in Nipah Virus Cases : A matter of public health concern?
New Microbes New Infect. 2023 Mar 30;53:101119. doi: 10.1016/j.nmni.2023.101119. eCollection 2023 Jun.
3
Development of Nipah virus-specific IgM & IgG ELISA for screening human serum samples.
Indian J Med Res. 2022 Sep;156(3):429-434. doi: 10.4103/ijmr.ijmr_2737_21.
本文引用的文献
1
Experiential learnings from the Nipah virus outbreaks in Kerala towards containment of infectious public health emergencies in India.
Epidemiol Infect. 2020 Apr 23;148:e90. doi: 10.1017/S0950268820000825.
2
Nipah Virus Sequences from Humans and Bats during Nipah Outbreak, Kerala, India, 2018.
Emerg Infect Dis. 2019 May;25(5):1003-1006. doi: 10.3201/eid2505.181076.
3
Nipah virus infection: A review.
Epidemiol Infect. 2019 Jan;147:e95. doi: 10.1017/S0950268819000086.
4
Diagnostics for Nipah virus: a zoonotic pathogen endemic to Southeast Asia.
BMJ Glob Health. 2019 Feb 1;4(Suppl 2):e001118. doi: 10.1136/bmjgh-2018-001118. eCollection 2019.
5
The pandemic potential of Nipah virus.
Antiviral Res. 2013 Oct;100(1):38-43. doi: 10.1016/j.antiviral.2013.07.011. Epub 2013 Jul 30.
6
Genomic characterization of Nipah virus, West Bengal, India.
Emerg Infect Dis. 2011 May;17(5):907-9. doi: 10.3201/eid1705.100968.
7
Person-to-person transmission of Nipah virus in a Bangladeshi community.
Emerg Infect Dis. 2007 Jul;13(7):1031-7. doi: 10.3201/eid1307.061128.
8
Nipah virus-associated encephalitis outbreak, Siliguri, India.
Emerg Infect Dis. 2006 Feb;12(2):235-40. doi: 10.3201/eid1202.051247.
9
Antibody prophylaxis and therapy against Nipah virus infection in hamsters.
J Virol. 2006 Feb;80(4):1972-8. doi: 10.1128/JVI.80.4.1972-1978.2006.
10
Nipah virus encephalitis reemergence, Bangladesh.
Emerg Infect Dis. 2004 Dec;10(12):2082-7. doi: 10.3201/eid1012.040701.
Zotero 插件